why choose us

First received: February 20, 2023

Clinical Trial: A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Eosinophilic Asthma

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Dexpramipexole Administered Orally for 24 Weeks in Participants With Eosinophil

Brief Summary: The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma to evaluate improvements in lung function, asthma control, and quality of life.In addition, the study will further evaluate the safety and tolerability of dexpramipexole in participants with eosinophilic asthma.

Read more